These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37860913)

  • 21. Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice.
    Ding ZB; Han QX; Wang Q; Song LJ; Chu GG; Guo MF; Chai Z; Yu JZ; Xiao BG; Li XY; Ma CG
    Neurosci Lett; 2021 May; 753():135880. PubMed ID: 33838256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
    Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
    Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The orphan G protein-coupled receptor GPR149 is a negative regulator of myelination and remyelination.
    Suo N; He B; Cui S; Yang Y; Wang M; Yuan Q; Xie X
    Glia; 2022 Oct; 70(10):1992-2008. PubMed ID: 35758525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unconventional Myosin ID is Involved in Remyelination After Cuprizone-Induced Demyelination.
    Yamazaki R; Baba H; Yamaguchi Y
    Neurochem Res; 2018 Jan; 43(1):195-204. PubMed ID: 28986688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular vesicles containing the transferrin receptor as nanocarriers of apotransferrin.
    Mattera VS; Pereyra Gerber P; Glisoni R; Ostrowski M; Verstraeten SV; Pasquini JM; Correale JD
    J Neurochem; 2020 Nov; 155(3):327-338. PubMed ID: 32248519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donepezil, a drug for Alzheimer's disease, promotes oligodendrocyte generation and remyelination.
    Cui X; Guo YE; Fang JH; Shi CJ; Suo N; Zhang R; Xie X
    Acta Pharmacol Sin; 2019 Nov; 40(11):1386-1393. PubMed ID: 30918344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin therapy inhibits remyelination in the central nervous system.
    Miron VE; Zehntner SP; Kuhlmann T; Ludwin SK; Owens T; Kennedy TE; Bedell BJ; Antel JP
    Am J Pathol; 2009 May; 174(5):1880-90. PubMed ID: 19349355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.
    Silvestroff L; Bartucci S; Pasquini J; Franco P
    Exp Neurol; 2012 May; 235(1):357-67. PubMed ID: 22421533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendrosomal nanocurcumin promotes remyelination through induction of oligodendrogenesis in experimental demyelination animal model.
    Motavaf M; Sadeghizadeh M; Babashah S; Zare L; Javan M
    J Tissue Eng Regen Med; 2020 Oct; 14(10):1449-1464. PubMed ID: 32750189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination.
    Li C; Xiao L; Liu X; Yang W; Shen W; Hu C; Yang G; He C
    Glia; 2013 May; 61(5):732-49. PubMed ID: 23440860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
    Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
    Fletcher JL; Wood RJ; Nguyen J; Norman EML; Jun CMK; Prawdiuk AR; Biemond M; Nguyen HTH; Northfield SE; Hughes RA; Gonsalvez DG; Xiao J; Murray SS
    J Neurosci; 2018 Aug; 38(32):7088-7099. PubMed ID: 29976621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paving the way for adequate myelination: The contribution of galectin-3, transferrin and iron.
    Franco PG; Pasquini LA; Pérez MJ; Rosato-Siri MV; Silvestroff L; Pasquini JM
    FEBS Lett; 2015 Nov; 589(22):3388-95. PubMed ID: 26296311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-146a promotes remyelination in a cuprizone model of demyelinating injury.
    Zhang J; Zhang ZG; Lu M; Wang X; Shang X; Elias SB; Chopp M
    Neuroscience; 2017 Apr; 348():252-263. PubMed ID: 28237816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transferrin Receptor Is Necessary for Proper Oligodendrocyte Iron Homeostasis and Development.
    Cheli VT; Santiago González DA; Wan R; Rosenblum SL; Denaroso GE; Angeliu CG; Smith Z; Wang C; Paez PM
    J Neurosci; 2023 May; 43(20):3614-3629. PubMed ID: 36977582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.
    Patel JR; Williams JL; Muccigrosso MM; Liu L; Sun T; Rubin JB; Klein RS
    Acta Neuropathol; 2012 Dec; 124(6):847-60. PubMed ID: 22933014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractalkine enhances oligodendrocyte regeneration and remyelination in a demyelination mouse model.
    de Almeida MMA; Watson AES; Bibi S; Dittmann NL; Goodkey K; Sharafodinzadeh P; Galleguillos D; Nakhaei-Nejad M; Kosaraju J; Steinberg N; Wang BS; Footz T; Giuliani F; Wang J; Sipione S; Edgar JM; Voronova A
    Stem Cell Reports; 2023 Feb; 18(2):519-533. PubMed ID: 36608690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions.
    Islam MS; Tatsumi K; Okuda H; Shiosaka S; Wanaka A
    Neurochem Int; 2009; 54(3-4):192-8. PubMed ID: 19070638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The K
    Albrecht S; Korr S; Nowack L; Narayanan V; Starost L; Stortz F; Araúzo-Bravo MJ; Meuth SG; Kuhlmann T; Hundehege P
    Glia; 2019 May; 67(5):870-883. PubMed ID: 30623969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice.
    Martin NA; Molnar V; Szilagyi GT; Elkjaer ML; Nawrocki A; Okarmus J; Wlodarczyk A; Thygesen EK; Palkovits M; Gallyas F; Larsen MR; Lassmann H; Benedikz E; Owens T; Svenningsen AF; Illes Z
    Front Immunol; 2018; 9():490. PubMed ID: 29593734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.